What Is Venlafaxine?

Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant that's also used for chronic pain conditions. Brand names include Effexor and Effexor XR. While its cousin duloxetine has more FDA-approved pain indications, venlafaxine is sometimes used off-label for various pain conditions.1

How It Helps Pain2

  • Increases serotonin and norepinephrine
  • Enhances descending pain inhibition
  • Works on pain pathways in brain/spinal cord
  • May be more effective at higher doses
  • Different from typical pain relievers

Pain Conditions (Off-Label)

  • Diabetic neuropathy
  • Other neuropathic pain
  • Fibromyalgia
  • Migraine prevention
  • Tension headache prevention
  • Chronic pain with depression

Dosing for Pain3

  • Start low: 37.5-75 mg daily
  • Increase gradually
  • Pain effects may need higher doses
  • 150-225 mg or more for pain
  • Extended-release preferred
  • Takes weeks for full effect

Common Side Effects

  • Nausea
  • Headache
  • Dizziness
  • Insomnia
  • Dry mouth
  • Constipation
  • Sweating
  • Sexual dysfunction

Serious Concerns

  • Blood pressure increase (monitor)
  • Suicidal thoughts (young adults)
  • Serotonin syndrome (with other drugs)
  • Severe withdrawal symptoms
  • Never stop suddenly

Blood Pressure

  • Can increase blood pressure
  • Monitor regularly
  • Higher doses = higher risk
  • Caution if hypertension exists

Withdrawal Caution

  • Very short half-life
  • Withdrawal can be severe
  • Must taper very slowly
  • "Brain zaps" common if stopped quickly
  • Work with doctor on tapering

Drug Interactions

  • MAO inhibitors (avoid)
  • Other serotonergic drugs
  • Blood thinners
  • Tramadol
  • Review with pharmacist

Compared to Duloxetine

  • Similar mechanism
  • Duloxetine has FDA pain approvals
  • Venlafaxine used when duloxetine fails
  • Some prefer one over other
  • Individual response varies

References

  1. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;(4):CD005454.
  2. Aiyer R, Barkin RL, Bhatia A. Treatment of neuropathic pain with venlafaxine: a systematic review. Pain Med. 2017;18(10):1999-2012.
  3. Gallagher HC, Gallagher RM, Butler M, et al. Venlafaxine for neuropathic pain in adults. Cochrane Database Syst Rev. 2015;(8):CD011091.